Clinical-immunological Features of Anti-NMDAR Encephalitis (Bio-NMDAr)

Civil Hospices of Lyon

Status: Active, not recruiting

Conditions: Anti NMDA Receptor Encephalitis

Treatments: Other: Description of clinical characteristic

Study type: Observational

Funder types: Other

Identifiers

NCT05738668

750

Details and patient eligibility

About

Using a retrospective cohort of 501 patients with anti-NMDAR encephalitis to assess clinical and immunological prognostic biomarkers

Enrollment: 400 estimated patients

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with neurological disorder
• Patient with NMDAR antibodies in sera or CSF

Exclusion criteria

• • No available clinical data
• Patient without NMDAR antibodies or neurological disorder

Trial design

400 participants in 1 patient group

Anti-NMDAR encephalitis

Description:

Patients with well-characterized anti-NMDAR encephalitis.

Treatment:

Other: Description of clinical characteristic